Mandelboim O, Kent S, Davis D M, Wilson S B, Okazaki T, Jackson R, Hafler D, Strominger J L
Department of Molecular and Cellular Biology, Harvard University, 7 Divinity Avenue, Cambridge, MA 01238, USA.
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3798-803. doi: 10.1073/pnas.95.7.3798.
Proliferation of human CD4+ alphabeta T cells expressing a natural killer cell activating receptor (NKAR) has been shown to be enhanced, particularly in response to low doses of antigen, if the target cells present appropriate human class I major histocompatibility complex (MHC) molecules. Here, we show that NKAR also enhance proliferation and killing of target cells by subsets of CD8+ alphabeta and CD8+ gammadelta T cells, as well as by NK cells. Strikingly, interferon gamma secretion from all of these types of lymphocytes was markedly increased by interaction of the NKAR with their MHC class I ligands, independently of enhancement of proliferation. Thus, the recognition of class I MHC molecules by NKAR on both T cells and NK cells may provide a regulatory mechanism that affects immune responses through the secretion of interferon gamma and possibly other cytokines. It represents a signal for cytokine secretion alternative and/or augmentative to that through the T cell receptor.
如果靶细胞呈现合适的人类I类主要组织相容性复合体(MHC)分子,已显示表达自然杀伤细胞激活受体(NKAR)的人类CD4 +αβ T细胞的增殖会增强,尤其是对低剂量抗原的反应。在此,我们表明NKAR还可增强CD8 +αβ和CD8 +γδ T细胞亚群以及NK细胞对靶细胞的增殖和杀伤作用。令人惊讶的是,NKAR与其MHC I类配体相互作用可显著增加所有这些类型淋巴细胞的干扰素γ分泌,且与增殖增强无关。因此,T细胞和NK细胞上的NKAR对I类MHC分子的识别可能提供一种调节机制,通过分泌干扰素γ以及可能的其他细胞因子来影响免疫反应。它代表了一种通过T细胞受体分泌细胞因子的替代和/或增强信号。